These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1197734)

  • 21. Quantitative EEG changes in the human menstrual cycle.
    Sugerman AA; DeBruin AT; Roth CW
    Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):526-34. PubMed ID: 5535650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations.
    Demacker PN; Schade RW; Stalenhoef AF; Stuyt PM; van't Laar A
    Br Med J (Clin Res Ed); 1982 Apr; 284(6324):1213-5. PubMed ID: 6803905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiological responses to cold in relation to the phase of the menstrual cycle and oral contraceptives.
    Grucza R; Pekkarinen H; Timonen K; Titov EK; Hänninen O
    Ann N Y Acad Sci; 1997 Mar; 813():697-701. PubMed ID: 9100957
    [No Abstract]   [Full Text] [Related]  

  • 24. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
    de Kretser DM; Burger HG; Dumpys R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in pure-tone thresholds and temporary threshold shifts as a function of menstrual cycle and oral contraceptives.
    Swanson SJ; Dengerink HA
    J Speech Hear Res; 1988 Dec; 31(4):569-74. PubMed ID: 3230886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of oral contraceptives on the variations in serum-iron during the menstrual cycle.
    Mardell M; Zilva JF
    Lancet; 1967 Dec; 2(7530):1323-5. PubMed ID: 4170025
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of low-dose oral contraceptives on female whole saliva.
    Laine M; Pienihäkkinen K; Ojanotko-Harri A; Tenovuo J
    Arch Oral Biol; 1991; 36(7):549-52. PubMed ID: 1837983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nucleic acids of mucous membrane cells of the corpus uteri in women in the course of the menstrual cycle induced by means of oral contraceptives].
    Rózewicki S
    Ann Acad Med Stetin; 1973; 0(0):5-60. PubMed ID: 4794550
    [No Abstract]   [Full Text] [Related]  

  • 29. Volume and copper concentration of menstrual discharge from women employing copper-7 and other types of contraceptives.
    Laufe LE; Gibor Y; McClanahan BJ; Wheeler RF
    Adv Plan Parent; 1974; 9():38-42. PubMed ID: 4468904
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduced uterine response to PGF2alpha under oral contraceptives.
    Shaala S; Khowessah M; EL-Damarawy H; E-Sahwi S; Osman M; Toppozada M
    Prostaglandins; 1977 Sep; 14(3):523-33. PubMed ID: 905576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine free dopamine in normal primigravid pregnancy and women taking oral contraceptives.
    Perkins CM; Hancock KW; Cope GF; Lee MR
    Clin Sci (Lond); 1981 Oct; 61(4):423-8. PubMed ID: 7285493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration by oral contraceptives of normal menstrual changes in plasma renin activity, concentration and substrate.
    Skinner SL; Lumbers ER; Symonds EM
    Clin Sci; 1969 Feb; 36(1):67-76. PubMed ID: 4306500
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast.
    Battersby S; Robertson BJ; Anderson TJ; King RJ; McPherson K
    Br J Cancer; 1992 Apr; 65(4):601-7. PubMed ID: 1562470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombin III and platelets during the normal menstrual cycle and in women receiving oral contraceptives low in oestrogen.
    Jespersen J; Ingeberg S; Bach E
    Gynecol Obstet Invest; 1983; 15(3):153-62. PubMed ID: 6832651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol content of menstrual discharge. Influence of contraceptives.
    DeMeere LJ; Gilbreath EB; Pattison DS
    Obstet Gynecol; 1968 Nov; 32(5):645-8. PubMed ID: 5742478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mood changes during the menstrual cycle and their relation to the use of oral contraceptive.
    Almagor M; Ben-Porath YS
    J Psychosom Res; 1991; 35(6):721-8. PubMed ID: 1791586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception.
    Christensen JT; Boldsen J; Westergaard JG
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):784-9. PubMed ID: 9348259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The menstrual cycle after withdrawal of oral contraceptives with particular reference to return of ovulation.
    Jordan K
    Mater Med Pol; 1975; 7(2):126-32. PubMed ID: 1142823
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes in insulin receptors during oral contraception.
    De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
    J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.